Syndesi Therapeutics, created in 2018 (United States), from 110 sister brands and 17478 competing brands. Syndesi Therapeutics is owned by ABBVIE INC., listed on the stock exchange of New York Syndesi Therapeutics belongs to the Drug Manufacturers business sector.

Syndesi Therapeutics is a brand of ABBVIE INC. (ABBV) Share price

Date created : 2018 Business sector Drug Manufacturers

Share price and profitability of the share ABBVIE INC. (Syndesi Therapeutics)

Buy ABBVIE INC. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 165.49

Portfolio valuation
ABBVIE INC. (Syndesi Therapeutics) over 5 years* USD 353.78

Stock market history ABBVIE INC. (Syndesi Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ABBVIE INC.

DJS Antibodies
DJS Antibodies
Mitokinin
Mitokinin
Stemcentrx
Stemcentrx
Pharmacyclics
Pharmacyclics
ImmuVen
ImmuVen
Envy Medical
Envy Medical
See more brands of ABBVIE INC.

Rival brands
Syndesi Therapeutics

Fusion Pharmaceuticals
Fusion Pharmaceuticals
POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS